Gender Nonconforming Youth
Pediatric Annals June 2014
Table of Contents
Understanding Gender Variance in Children and Adolescents
Lisa K. Simons, MD; Scott F. Leibowitz, MD; and Marco A. Hidalgo, PhD
The Peripubertal Gender-Dysphoric Child: Puberty Suppression and Treatment Paradigms
Johanna Olson, MD; and Robert Garofalo, MD, MPH
Cross-Gender Hormone Therapy in Adolescents
John Steever, MD
Beyond the Guidelines: Challenges, Controversies, and Unanswered Questions
Anita Radix, MD, MPH, FACP; and Manel Silva, MD, MPH
Sponsorship Statement: This continuing medical education activity is jointly sponsored by Keck School of Medicine of USC and Pediatric Annals.
Support Statement: There is no commercial support for this activity.
1. Distinguish between different aspects of gender, including gender expression, gender identity, and gender behaviors.
2. Describe gender dysphoria as it may occur in the peripubertal child..
3. Introduce common medications used in transgender health; their dosages, desired effects, side effects, and time course of action.
4. Describe the risks and benefi ts of medical transition for transgender adolescents.
Faculty names and affiliations: See Table of Contents
Reviewer names: Thomas J. Selva, MD, CME Director, Pediatric Annals; Stanford T. Shulman, Editor-in-chief, Pediatric Annals
Guest Editor: Robert Garofalo, MD
Disclosure statement: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.
Faculty, reviewer and staff disclosures:
Susan Donlevy, RN, MSN, CPNP, has disclosed no relevant financial relationships.
Deepak Kamat, MD, PhD, has disclosed no relevant financial relationships.
Leonard R. Krilov, MD, PhD, has disclosed the following relevant financial relationships: Medimmune and Merck: Consultant; GlaxoSmithKline, Medimmune, and Novartis: Grant recipient; and GSK, Medimmune, and Merck: Member of speakers’ bureau..
Faculty members report the following financial relationships:
Robert Listernick, MD, has disclosed no relevant financial relationships.
Thomas J. Selva, MD, has disclosed no relevant financial relationships.
Stanford T. Shulman, MD, has disclosed no relevant financial relationships.
Robert R. Tanz, MD, has disclosed no relevant financial relationships.
Authors report the following financial relationships:
Lisa K. Simons has no relevant financial relationships to disclose. Scott F. Leibowitz has no relevant financial relationships to disclose. Marco A. Hidalgo has no relevant financial relationships to disclose. Johanna Olson has no relevant financial relationships to disclose. Robert Garofalo has no relevant financial relationships to disclose. John Steever has no relevant financial relationships to disclose. Anita Radix has no relevant financial relationships to disclose. Manel Silva has no relevant financial relationships to disclose.
The staff of Keck School of Medicine of USC and Pediatric Annals have disclosed no relevant financial relationships.
Signed disclosures are on file at Keck School of Medicine of USC.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Keck School of Medicine of USC and Pediatric Annals. Keck School of Medicine of USC is accredited by the ACCME to provide continuing medical education for physicians.
Credit designation: The Keck School of Medicine of USC designates this enduring material for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release date: June 1, 2014.
Expiration Date: June 30, 2017.
How to participate: To participate in this CME activity, you must read the learning objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Keck School of Medicine of USC will issue an AMA PRA Category 1 Credit(s)™ certificate.
Target audience: This CME activity is primarily targeted to pediatricians, osteopathic physicians, pediatric nurse practitioners, and others allied to the field. There are no specific background requirements for participants taking this activity. Learning objectives are found at the beginning of each CME article.
Unlabeled and Investigational Usage Statement: The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.
Copyright Statement: Copyright © 2014 by SLACK Incorporated. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher.